|
1
|
Plummer M, Franceschi S, Vignat J, Forman
D and de Martel C: Global burden of gastric cancer attributable to
Helicobacter pylori. Int J Cancer. 136:487–490. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Anderson WF, Rabkin CS, Turner N, Fraumeni
JF Jr, Rosenberg PS and Camargo MC: The changing face of noncardia
gastric cancer incidence among US non-hispanic whites. J Natl
Cancer Inst. 110:608–615. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mocellin S, Verdi D, Pooley KA and Nitti
D: Genetic variation and gastric cancer risk: A field synopsis and
meta-analysis. Gut. 64:1209–1219. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang Z, Zhu D, Wu L, He M, Zhou X, Zhang
L, Zhang H, Wang W, Zhu J, Cheng W, et al: Six serum-based miRNAs
as potential diagnostic biomarkers for gastric cancer. Cancer
Epidemiol Biomarkers Prev. 26:188–196. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma J, Shen H, Kapesa L and Zeng S: Lauren
classification and individualized chemotherapy in gastric cancer.
Oncol Lett. 11:2959–2964. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xue X, Yang YA, Zhang A, Fong KW, Kim J,
Song B, Li S, Zhao JC and Yu J: LncRNA HOTAIR enhances ER signaling
and confers tamoxifen resistance in breast cancer. Oncogene.
35:2746–2755. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun M, Nie F, Wang Y, Zhang Z, Hou J, He
D, Xie M, Xu L, De W, Wang Z, et al: LncRNA HOXA11-AS promotes
proliferation and invasion of gastric cancer by scaffolding the
chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Res.
76:6299–6310. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang C, Yu W, Wang Q, Cui H, Wang Y,
Zhang L, Han F and Huang T: Increased expression of the lncRNA PVT1
is associated with poor prognosis in pancreatic cancer patients.
Minerva Med. 106:143–149. 2015.PubMed/NCBI
|
|
9
|
Zhao L, Kong H, Sun H, Chen Z, Chen B and
Zhou M: LncRNA-PVT1 promotes pancreatic cancer cells proliferation
and migration through acting as a molecular sponge to regulate
miR-448. J Cell Physiol. 233:4044–4055. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu HT, Fang L, Cheng YX and Sun Q: LncRNA
PVT1 regulates prostate cancer cell growth by inducing the
methylation of miR-146a. Cancer Med. 5:3512–3519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu J, Han J, Zhang J, Li G, Liu H, Cui X,
Xu Y, Li T, Liu J and Wang C: The long noncoding RNAs PVT1 and
uc002mbe.2 in sera provide a new supplementary method for
hepatocellular carcinoma diagnosis. Medicine (Baltimore).
95:e44362016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoshida K, Toden S, Ravindranathan P, Han
H and Goel A: Curcumin sensitizes pancreatic cancer cells to
gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1
expression. Carcinogenesis. 38:1036–1046. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao J, Du P, Cui P, Qin Y, Hu C, Wu J,
Zhou Z, Zhang W, Qin L and Huang G: LncRNA PVT1 promotes
angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
Oncogene. 37:4094–4109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Z, Chen Z, Fan R, Jiang B, Chen X,
Chen Q, Nie F, Lu K and Sun M: Over-expressed long noncoding RNA
HOXA11-AS promotes cell cycle progression and metastasis in gastric
cancer. Mol Cancer. 16:822017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi SJ, Wang LJ, Yu B, Li YH, Jin Y and
Bai XZ: LncRNA-ATB promotes trastuzumab resistance and
invasion-metastasis cascade in breast cancer. Oncotarget.
6:11652–11663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou M, Hou Y, Yang G, Zhang H, Tu G, Du
YE, Wen S, Xu L, Tang X, Tang S, et al: LncRNA-Hh strengthen cancer
stem cells generation in twist-positive breast cancer via
activation of Hedgehog signaling pathway. Stem Cells. 34:55–66.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou M, Sun Y, Sun Y, Xu W, Zhang Z, Zhao
H, Zhong Z and Sun J: Comprehensive analysis of lncRNA expression
profiles reveals a novel lncRNA signature to discriminate
nonequivalent outcomes in patients with ovarian cancer. Oncotarget.
7:32433–32448. 2016.PubMed/NCBI
|
|
18
|
Niknafs YS, Han S, Ma T, Speers C, Zhang
C, Wilder-Romans K, Iyer MK, Pitchiaya S, Malik R, Hosono Y, et al:
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1
in breast cancer progression. Nat Commun. 7:127912016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang T, Liu HW, Chen JQ, Wang SH, Hao LQ,
Liu M and Wang B: The long noncoding RNA PVT1 functions as a
competing endogenous RNA by sponging miR-186 in gastric cancer.
Biomed Pharmacother. 88:302–308. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shen CJ, Cheng YM and Wang CL: LncRNA PVT1
epigenetically silences miR-195 and modulates EMT and
chemoresistance in cervical cancer cells. J Drug Target.
25:637–644. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wan L, Sun M, Liu GJ, Wei CC, Zhang EB,
Kong R, Xu TP, Huang MD and Wang ZX: Long noncoding RNA PVT1
promotes non-small cell lung cancer cell proliferation through
epigenetically regulating LATS2 expression. Mol Cancer Ther.
15:1082–1094. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Warner ET, Tamimi RM, Hughes ME, Ottesen
RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer
EP, et al: Racial and ethnic differences in breast cancer survival:
Mediating effect of tumor characteristics and sociodemographic and
treatment factors. J Clin Oncol. 33:2254–2261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Krammer J, Pinker-Domenig K, Robson ME,
Gönen M, Bernard-Davila B, Morris EA, Mangino DA and Jochelson MS:
Breast cancer detection and tumor characteristics in BRCA1 and
BRCA2 mutation carriers. Breast Cancer Res Treat. 163:565–571.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miglioretti DL, Zhu W, Kerlikowske K,
Sprague BL, Onega T, Buist DS, Henderson LM and Smith RA; Breast
Cancer Surveillance Consortium, : Breast tumor prognostic
characteristics and biennial vs annual mammography, age, and
menopausal status. JAMA Oncol. 1:1069–1077. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY,
Gong W and Quan ZW: Long non-coding RNA CCAT1 promotes gallbladder
cancer development via negative modulation of miRNA-218-5p. Cell
Death Dis. 6:e15832015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Madhavan B, Yue S, Galli U, Rana S, Gross
W, Müller M, Giese NA, Kalthoff H, Becker T, Büchler MW, et al:
Combined evaluation of a panel of protein and miRNA serum-exosome
biomarkers for pancreatic cancer diagnosis increases sensitivity
and specificity. Int J Cancer. 136:2616–2627. 2015. View Article : Google Scholar : PubMed/NCBI
|
